Be sure to whitelist the @drughunter.com domain in your e-mail inbox to make sure your free content doesn't get sent to spam!
From Our Subscribers
“I continue to be surprised on how the issues your publication touches on routinely seems to impact our work lives in the sense of prompting conversations, prompting literature or patent searches based on the work of others facing similar challenges. The value of this very direct effect can’t be overstated gi..."
Peter Meinke
Sanders Director, Tri-I TDI + 28 yrs at Merck
“I continue to be surprised on how the issues your publication touches on routinely seems to impact our work lives in the sense of prompting conversations, prompting literature or patent searches based on the work of others facing similar challenges. The value of this very direct effect can’t be overstated gi..."
Peter Meinke
Sanders Director, Tri-I TDI + 28 yrs at Merck
“Drug Hunter has been great. I regularly check with my team and they all say they like it and use it. My team has benefited from this site with keeping up to date of the latest and greatest. Drug Hunter provides facts, data and information that we can learn from. I have even used some of the sites info in my ..."
Anthony Romero
Sr. Director, Head of Chemistry, ORIC Pharma, prev. Genentech, Merck
“A colleague suggested I check out drughunter.com, and it quickly became a go-to resource for me to stay up-to-date with the field of small molecule drug discovery. Every week new content is added that is current, easy to preview and with citations for a deeper dive.”